All patents from AstraZeneca are available for research and development for NTD
| SUBMISSION ID | 1421 |
Contact Details |
|
|---|---|
| Provider | AstraZeneca - AZ |
| Partnership Hub Coordinator Name | BIO Ventures for Global Health 221 Main Street, Suite 1600 San Francisco, CA 94105 USA Tel: +1 415 446 94 43 partnershiphub@bvgh.org |
Submission Summary |
|
|---|---|
| Title | All patents from AstraZeneca are available for research and development for NTD |
| Executive Summary/Abstract | AstraZeneca is proud to make a commitment that all patents owned by AstraZeneca or MedImmune should be used to promote Neglected Tropical Diseases Research and Development and will therefore be available for royalty-free licensing under the terms of the WIPO Re:Search Guiding Principles. In view of this commitment, AZ is contributing the entire portfolio of patents and published patent applications which it owns, to WIPO Re:Search for license as above, subject only to any conflicting obligations to third parties existing prior to the request for such license. There is no intention to imply that all our contributed patent rights will have relevance to NTDs but in making this broad commitment we make clear that any such rights will be available to promote NTD Research and Development anywhere in the world. |
| Keywords | entire patent estate; portfolio; AstraZeneca PLC; Astra Zeneca; MedImmune; |
Disease Selection |
|
|---|---|
| Disease | Tuberculosis;Echinococcosis;Onchocerciasis;Leprosy;Snakebite;Foodborne trematode infections (Clonorchiasis, Fascioliasis, Opistorchiasis, Paragonimiasis);Cysticercosis;Buruli Ulcer;Malaria;Endemic treponematoses (Yaws);Leishmaniasis;Lymphatic filariasis;Dengue/dengue hemorrhagic fever;Human African trypanosomiasis;Dracunculiasis (guinea-worm disease);Rabies;Trachoma;Schistosomiasis;Chagas disease (American trypanosomiasis);Soil transmitted helminthiasis;Podoconiosis |
| Comment | |
| Name(s) of Infectious Organism(s) | |
| Vector(s) | |
| Human Target Organ(s) | |
| Mechanism of Action (MoA) | |
| Molecular or Cellular Target Name(s) | |
Type of Data |
|
|---|---|
| Type of Data | Intellectual Property |
INTELLECTUAL PROPERTY DATA SUBFIELDS |
|||
|---|---|---|---|
IP Description |
|||
| Summary/Abstract Text | Commitment that all patents owned by AstraZeneca or MedImmune should be used to promote NTD R and D and will therefore be available for royalty-free licensing under the terms of the WIPO Re:Search Guiding Principles. In view of this commitment, AZ is contributing the entire portfolio of patents and published patent applications which it owns, to WIPO Re:Search for license as above, subject only to any conflicting obligations to third parties existing prior to the request for such license. There is no intention to imply that all our contributed patent rights will have relevance to NTDs but in making this broad commitment we make clear that any such rights will be available to promote NTD R and D anywhere in the world. | ||
| Keywords | all IP; reverse genetic; | ||
| References | http://www.wipo.int/research/en/data/astrazeneca.html | ||
Benefits for Disease |
|||
| Field(s) of IP/Know-how Application | |||
| How to use IP/Know-how for Disease | |||
| Potential Benefits for Disease Application | |||
Publication/Patent Status |
|||
| Proprietary IP or Know-How | Yes | ||
| How many Patent Families | |||
| How many Granted Patents | |||
| Granted Patent Reference Number(s) | All patents can be searched here http://www.wipo.int/patentscope/search/en/search.jsf | ||
| How many Pending Patents | |||
| Pending Patent Reference Number(s) | |||
| How many Abandoned Patents | |||
| Abandoned Patent Reference Number(s) | |||
Collaboration Status |
|||
| In house only | Yes | ||
